| scholarly article | Q13442814 |
| P2093 | author name string | K Jurkat-Rott | |
| S Servidei | |||
| D C Camerino | |||
| D Tricarico | |||
| P Tonali | |||
| P2860 | cites work | A calcium channel mutation causing hypokalemic periodic paralysis | Q28242375 |
| Dihydropyridine receptor mutations cause hypokalemic periodic paralysis | Q28243593 | ||
| ATP-regulated K+ channels in cardiac muscle | Q28265565 | ||
| Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion | Q34308492 | ||
| Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle | Q36789864 | ||
| Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) | Q41057145 | ||
| Ion-channel defects and aberrant excitability in myotonia and periodic paralysis | Q41095963 | ||
| Molecular pathophysiology of voltage-gated ion channels | Q41100795 | ||
| Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. | Q41215041 | ||
| Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. | Q41510537 | ||
| Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition | Q42671954 | ||
| Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta | Q42674444 | ||
| The biophysical and pharmacological characteristics of skeletal muscle ATP-sensitive K+ channels are modified in K+-depleted rat, an animal model of hypokalemic periodic paralysis | Q42680605 | ||
| Effects of potassium depletion and insulin on resting and stimulated skeletal rat muscle | Q42723278 | ||
| Nucleotide diphosphates activate the ATP-sensitive potassium channel in mouse skeletal muscle | Q44606161 | ||
| Different sulfonylurea and ATP sensitivity characterizes the juvenile and the adult form of KATP channel complex of rat skeletal muscle. | Q52195735 | ||
| Low-conductance states of K+ channels in adult mouse skeletal muscle. | Q53767397 | ||
| Changes of the biophysical properties of calcium-activated potassium channels of rat skeletal muscle fibres during aging. | Q53963663 | ||
| Modulation of ATP-sensitive K+ channel by insulin in rat skeletal muscle fibers. | Q53971983 | ||
| ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties. | Q54022623 | ||
| Insulin modulation of ATP-sensitive K+ channel of rat skeletal muscle is impaired in the hypokalaemic state. | Q54106462 | ||
| Enhancement of K+ conductance improves in vitro the contraction force of skeletal muscle in hypokalemic periodic paralysis | Q68798219 | ||
| Insulin-induced hyperpolarization in mammalian skeletal muscle | Q69486736 | ||
| Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres | Q69617777 | ||
| Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? | Q70490489 | ||
| Normal insulin release during sustained hyperglycaemia in hypokalaemic periodic paralysis: role of the potassium channel opener pinacidil in impaired muscle strength | Q71832047 | ||
| Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families | Q72017458 | ||
| Cytoplasmic acidosis induces multiple conductance states in ATP-sensitive potassium channels of cardiac myocytes | Q72239336 | ||
| Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis | Q73299439 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenosine triphosphate | Q80863 |
| hypokalemic periodic paralysis | Q622828 | ||
| P304 | page(s) | 675-682 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis | |
| P478 | volume | 103 |
| Q36498120 | A calcium channel mutant mouse model of hypokalemic periodic paralysis |
| Q40024967 | A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels |
| Q26744723 | ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force |
| Q34589475 | Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+) -depleted rats. |
| Q35171519 | Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations |
| Q34738564 | An expanding view for the molecular basis of familial periodic paralysis |
| Q60708365 | Calcium Channelopathies |
| Q28082428 | Channelopathies of skeletal muscle excitability |
| Q33944905 | Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle |
| Q35045276 | Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel |
| Q48907500 | Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes |
| Q79448284 | Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis |
| Q34811193 | Genetic disorders of neuromuscular ion channels |
| Q33906965 | Human K(ATP) channelopathies: diseases of metabolic homeostasis |
| Q34304691 | Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties |
| Q36774708 | Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder |
| Q35663783 | Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations. |
| Q48725401 | Inherited muscle and brain channelopathies |
| Q44619139 | Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin |
| Q59467325 | Ion channels in muscle and cardiac hereditary diseases: from gene dysfunction to pharmacological therapy |
| Q36161668 | K(ATP) channel therapeutics at the bedside |
| Q46202283 | Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: pharmacological perspectives. |
| Q37685726 | Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis? |
| Q82140254 | Mutation screening in Chinese hypokalemic periodic paralysis patients |
| Q24291252 | Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome |
| Q33841654 | Neurological channelopathies: diagnosis and therapy in the new millennium |
| Q37873716 | Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. |
| Q34015907 | Periodic paralysis |
| Q82029865 | Periodic paralysis |
| Q34566685 | Periodic paralysis: understanding channelopathies |
| Q34481593 | Peripheral channelopathies as targets for potassium channel openers |
| Q41955529 | Potassium dependent rescue of a myopathy with core-like structures in mouse |
| Q35025840 | Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies |
| Q38698910 | Skeletal muscle na channel disorders |
| Q34011949 | Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis |
| Q37711046 | Sodium channelopathies of skeletal muscle result from gain or loss of function |
| Q43197438 | The KATP channel is a molecular sensor of atrophy in skeletal muscle. |
| Q36272858 | The primary periodic paralyses: diagnosis, pathogenesis and treatment |
| Q33510262 | The role of CACNA1S in predisposition to malignant hyperthermia |
| Q34927551 | Therapeutic approaches to ion channel diseases |
| Q50282530 | Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients |
| Q37329554 | Treatment of neuromuscular channelopathies: current concepts and future prospects |
| Q37692699 | Voltage-sensor mutations in channelopathies of skeletal muscle |
| Q35208537 | Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current |
Search more.